{"entity":{"id":"hagen-kennecke","kind":"person","name":"Hagen F. Kennecke","aka":[],"tldr":"Hagen Kennecke is a GI oncologist who leads SWOG's gastrointestinal and melanoma committees.","summary":"Hagen Kennecke is SWOG Executive Officer for Gastrointestinal and Melanoma and Professor at Oregon Health & Science University. A medical oncologist specialising in gastrointestinal oncology and rectal cancer, his work focuses on rectal and colorectal cancer trials, including total neoadjuvant therapy studies. His papers include the primary end point results of the phase II NEO trial (CCTG CO.28) of neoadjuvant chemotherapy, excision and observation for early rectal cancer in the Journal of Clinical Oncology, and an earlier study of the metastatic behaviour of breast cancer subtypes. He now leads SWOG's gastrointestinal and melanoma committees within the SWOG Cancer Research Network.","asOf":"2026-09-08","links":[{"label":"SWOG leadership","url":"https://www.swog.org/about/leadership"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Kennecke%20HF%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Hagen%20F.%20Kennecke"}],"tags":[],"related":[],"cancers":["colorectal","melanoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["swog"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"SWOG Executive Officer, Gastrointestinal and Melanoma; Professor, Oregon Health & Science University","institutionId":"swog","specialisms":["Gastrointestinal oncology","Rectal cancer","Cooperative group trials"],"profiles":[{"label":"SWOG leadership","url":"https://www.swog.org/about/leadership"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Kennecke%20HF%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Hagen%20F.%20Kennecke"}],"papers":[{"title":"Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results","journal":"Journal of Clinical Oncology","year":2023,"url":"https://doi.org/10.1200/JCO.22.00184","doi":"10.1200/JCO.22.00184"},{"title":"Metastatic behavior of breast cancer subtypes","journal":"Journal of Clinical Oncology","year":2010,"url":"https://doi.org/10.1200/JCO.2009.25.9820","doi":"10.1200/JCO.2009.25.9820"}]},"route":"/people/hagen-kennecke/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"}],"company":[{"id":"swog","kind":"company","name":"SWOG Cancer Research Network","route":"/companies/swog/"}]}}